NCT05051189

Brief Summary

Children OSA exhibit varying responses to opioids. It is unknown if the degree of intermittent hypoxemia results in different opioid sensitivity

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P75+ for early_phase_1

Timeline
Completed

Started Dec 2021

Typical duration for early_phase_1

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 2, 2021

Completed
19 days until next milestone

First Posted

Study publicly available on registry

September 21, 2021

Completed
2 months until next milestone

Study Start

First participant enrolled

December 1, 2021

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2024

Completed
Last Updated

April 6, 2025

Status Verified

April 1, 2025

Enrollment Period

2.9 years

First QC Date

September 2, 2021

Last Update Submit

April 3, 2025

Conditions

Outcome Measures

Primary Outcomes (3)

  • Respiratory depression following opioids

    Identification of respiratory depression following fentanyl administration by recording the respiratory rate prior to and 10 minutes following fentanyl administration

    respiratory rate measured at each minute for 10 consecutive minutes following opioid administration

  • Respiratory depression following opioids

    Identification of respiratory depression following fentanyl administration by recording the tidal volume prior to and 10 minutes following fentanyl administration

    tidal volume measured at each minute for 10 consecutive minutes following opioid administration

  • Respiratory depression following opioids

    Identification of respiratory depression following fentanyl administration by recording the end-tidal co2 prior to and 10 minutes following fentanyl administration

    end tidal co2 measured at each minute for 10 consecutive minutes following opioid administration

Study Arms (4)

Patients with sleep apnea having oxygen Saturation >85% randomized to fentanyl 1.0/kg

ACTIVE COMPARATOR

Children with OSA having procedures requiring endotracheal intubation and a who will receive opioids (1.0 mcg/kg fentanyl for IBW, max 25 mcg) for evaluation of respiratory changes.

Drug: Fentanyl Citrate

Patients with sleep apnea having oxygen Saturation <85% randomized to 1.0 mcg/kg fentanyl

ACTIVE COMPARATOR

Children without OSA having procedures requiring endotracheal intubation and an who will receive opioids (1.0 mcg/kg fentanyl for IBW, max 25 mcg) for evaluation of respiratory changes

Drug: Fentanyl Citrate

Patients with sleep apnea having oxygen Saturation >85% randomized to fentanyl 1.5/kg

ACTIVE COMPARATOR

Children with OSA having procedures requiring endotracheal intubation and a who will receive opioids (1.5 mcg/kg fentanyl for IBW, max 25 mcg) for evaluation of respiratory changes.

Drug: Fentanyl Citrate

Patients with sleep apnea having oxygen Saturation <85% randomized to 1.5 mcg/kg fentanyl

ACTIVE COMPARATOR

Children with OSA having procedures requiring endotracheal intubation and a who will receive opioids (1.5 mcg/kg fentanyl for IBW, max 25 mcg) for evaluation of respiratory changes.

Drug: Fentanyl Citrate

Interventions

Ventilatory response to fentanyl in patients with OSA Specifically: respiratory changes, CO2, RR, TV

Patients with sleep apnea having oxygen Saturation <85% randomized to 1.0 mcg/kg fentanylPatients with sleep apnea having oxygen Saturation <85% randomized to 1.5 mcg/kg fentanylPatients with sleep apnea having oxygen Saturation >85% randomized to fentanyl 1.0/kgPatients with sleep apnea having oxygen Saturation >85% randomized to fentanyl 1.5/kg

Eligibility Criteria

Age2 Years - 8 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Patients undergoing tonsillectomy or adenotonsillectomy
  • Ages 2 to up to 8 years
  • Preoperative sleep study demonstrating obstructive sleep apnea
  • Intubation without medication (e.g. no propofol prior to intubation)
  • Requirement for airway instrumentation: LMA or ETT
  • Inhalation induction of anesthesia

You may not qualify if:

  • No obstructive sleep apnea
  • Central sleep apnea events \>5/hour
  • IV induction of anesthesia
  • Syndromic patients
  • Known or suspected difficult airway
  • Allergy to Fentanyl
  • Known cardiovascular medications
  • Pulmonary hypertension
  • Total intravenous anesthesia required
  • Parental refusal

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Texas childrens Hospital

Houston, Texas, 77030, United States

Location

Related Publications (2)

  • Adler AC, Chandrakantan A, Nathanson BH, von Ungern-Sternberg BS. An assessment of opioids on respiratory depression in children with and without obstructive sleep apnea. Paediatr Anaesth. 2021 Sep;31(9):977-984. doi: 10.1111/pan.14228. Epub 2021 Jun 16.

    PMID: 34053151BACKGROUND
  • Adler AC, Lin EE, Messner AH, Rosenberg TL, Pecorella S, Keleghan A, Faircloth S, Templeton TW, Harris L, Khan SA, Pednekar GS, Nguyen DT, Chandrakantan A, von Ungern-Sternberg BS. Association of preoperative nocturnal hypoxaemia nadir and fentanyl ventilatory sensitivity in children with obstructive sleep apnoea undergoing general anaesthesia: a multicentre clinical cohort study. Br J Anaesth. 2025 Nov;135(5):1518-1527. doi: 10.1016/j.bja.2025.07.059. Epub 2025 Sep 5.

MeSH Terms

Interventions

Fentanyl

Intervention Hierarchy (Ancestors)

PiperidinesHeterocyclic Compounds, 1-RingHeterocyclic Compounds

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
The participant will be unaware of the arm
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Model Details: 2 groups will be identified- 1. patients with sleep study O2 nadir \>85% 2. patients with sleep study O2 nadir \<85%
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor of Anesthesiology

Study Record Dates

First Submitted

September 2, 2021

First Posted

September 21, 2021

Study Start

December 1, 2021

Primary Completion

November 1, 2024

Study Completion

November 1, 2024

Last Updated

April 6, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will share

De-identified data will be made available at the conclusion of the study upon reasonable written request to the PI

Shared Documents
STUDY PROTOCOL, SAP, CSR
Time Frame
De-identified raw data will be available upon study completion following written request to the PI. There will be no time restriction on data
Access Criteria
Written request

Locations